Vigil Neuroscience (NASDAQ:VIGL) Rating Lowered to Hold at William Blair
William Blair lowered shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) from a strong-buy rating to a hold rating in a research note released on Thursday morning, Marketbeat reports. William Blair also issued estimates for Vigil Neuroscience’s FY2027 earnings at ($1.78) EPS. Several other equities research analysts have also commented on VIGL. Wedbush restated an […]
William Blair lowered shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) from a strong-buy rating to a hold rating in a research note released on Thursday morning, Marketbeat reports. William Blair also issued estimates for Vigil Neuroscience’s FY2027 earnings at ($1.78) EPS. Several other equities research analysts have also commented on VIGL. Wedbush restated an […]
